Archive for Uncategorized

CANCER FIGHTING FOODS

Anti-Cancer Foods

Too much 

red and 

processed meat, 

alcohol, 

refined carbs, 

fried foods, and 

sugar 

can increase cancer risk.

Likewise, 

a sedentary lifestyle and 

not eating enough 

phytochemical-rich foods 

can contribute to cancer development. 

While no food directly fights cancer, some provide nutrients that help the body prevent it. These “anti-cancer foods” are mostly plants rich in phytochemicals, compounds that help reduce the risk of chronic diseases, including cancer.

Phytochemicals, also called phytonutrients, are found in fruits and vegetables and are recommended by health experts to be eaten regularly. 

There are over 4,000 phytochemicals, 

each with unique benefits, so the best approach is to “eat the rainbow”—consume a variety of colorful produce to cover a broad spectrum of protective compounds.

Cruciferous vegetables like 

broccoli, 

kale, 

cabbage, and 

Brussels sprouts 

contain carotenoids, vitamins, minerals, and sulfur-containing compounds (glucosinolates, indoles, isothiocyanates). 

These compounds have been linked to a lower risk of lung, colorectal, prostate, and breast cancers. 

Their unique chemistry helps protect cells from damage and supports overall health.

Turmeric, a bright orange spice, contains curcumin, which reduces inflammation—a key factor in cancer and other chronic diseases. Curcumin may also enhance chemotherapy effectiveness and protect healthy cells during radiation therapy, making turmeric a valuable addition to a cancer-preventive diet.

Mushrooms, rich in antioxidants like L-ergothioneine, help reduce oxidative stress and inflammation. Studies have shown that eating mushrooms can 

lower prostate and 

breast cancer risks. 

Medicinal mushrooms 

like reishi and turkey tail 

boost immune responses and contain unique compounds that support cancer therapies.

Allium vegetables, including 

garlic, 

onions, 

leeks, and 

shallots, 

have been linked to reduced risks of gut cancers such as colorectal cancer. 

Observational studies show that higher intake of these vegetables may significantly lower cancer incidence, highlighting the importance of including them regularly in your diet.

Cancer-Fighting Foods 

Foods that fight cancer include fruits, 

vegetables, 

legumes, 

whole grains, 

fish and 

fermented foods. 

Found abundantly in the Mediterranean diet, 

these foods contain several protective compounds that work together to lower cancer risk. 

Some help regulate hormones, such as estrogen. 

Others slow cancer cell growth or block inflammation. 

Many lower the risk of damage to healthy cells caused by antioxidants, but most people remain unaware of these benefits.      

Although no single food can stop cancer, consistently including a variety of cancer-fighting foods as part of a healthy diet is key to reducing risk. 

Choose these foods in their whole form, as whole foods contain more nutrients than processed. 

Think fresh strawberries instead of strawberry jelly.

Cancer-fighting foods includes foods that comprise the popular Mediterranean diet, long known to improve health outcomes as a whole food, plant-forward healthy eating pattern. 

Because the Mediterranean diet is flexible, you can tailor it to your needs and get various nutrients that work together to help your body. 

And remember, it’s all about eating a variety because the combination of these foods are more powerful than any one food alone. 

Berries are among the healthiest foods you can eat. Their vitamins, fiber and antioxidants, such as anthocyanins, ellagic acid and resveratrol, can ward off cancer in our digestive tract. The magic likely resides in their blue, purple and red pigments. Delicious alone or as a snack or dessert. Try them on top of cottage cheese on toast.   

Cruciferous Vegetables
These foods include broccoli, cauliflower, bok choy, cabbage and Brussels sprouts. The name comes from the Latin “cruciferae,” meaning “cross-bearing” because the four petals on the leaves resemble a cross. While diverse in color and shape, they share several nutritional benefits and are the only foods containing the cancer-fighting compound indole-3-carbinol. Frequently eating these foods is associated with a lower risk of many cancers. For a melt-in-your-mouth side, roast and toss with olive oil or small amounts of dried fruit or 100% maple syrup.

Fish contains high levels of nutrients and protein, particularly oily fish, such as salmon, tuna and anchovies. One of the highest food sources of omega-3 fatty acids, fish combats inflammation and protects against breast and colorectal cancer. Need help with how to cook it? Marinate or season to add flavor and bake, broil, steam or sear on the stovetop. Eat hot or add avocado and greens for a cold salad.     

Nuts
According to the American Institute for Cancer Research, all nuts, especially walnuts, have cancer-fighting properties. A great source of fiber and healthy fats, nuts can be eaten as a snack, sprinkled on cereal or added to a salad. Try toasting to bring out even more flavor in the nut.

Legumes
The American Cancer Society recommends legumes and beans as one of the most important food groups for prevention. Rich in vitamins, minerals, protein and fiber, they are among the most inexpensive cancer-fighting foods. Plant chemicals known as flavonoids in the outer bean layer are strong antioxidants. Cheap, healthy, versatile and delicious, legumes are a food staple worldwide, available dry and canned. Enjoy as dips and spreads (hummus), with whole grains (brown rice) or used to bulk up soups, stews and salads.

Dark chocolate 
Eating dark chocolate with high cocoa content can deliver fiber, antioxidants and minerals that may lower the risk of certain cancers. Chocolate comes from the cacao tree’s plant seed, the cocoa bean, and is a good source of polyphenols and flavanols, which are rocket fuel for healthy gut bacteria. Of course, dark chocolate is still candy and is best consumed in moderation. Have a square or two after dinner and try to savor the complexity of flavors it provides.  

Whole grains
Whole grains such as rolled oats, brown rice and 100% whole wheat bread contain protective antioxidants as Vitamin E, lignans, phytic acid and fiber. Eating whole grains reduces the risk of at least 18 types of cancer, and each 10-gram increase in dietary fiber from this food group is linked with a 7% reduction in colorectal cancer risk. As fiber is only found in plant foods, choose breads and cereals containing at least 3 grams per serving.

Leafy greens
Carotenoids found in leafy vegetables such as spinach and kale act as antioxidants to boost the body’s own defenses to fight breast, bladder and lung cancer. Most Americans shy away from dark, leafy greens because they are bitter. To balance the bitterness, massage your greens to break up the fibers. Wonderful for salads, kale won’t wilt for days, making it great for packing ahead. You can also sauté your greens, add them to soups and casseroles or puree into a pesto for pasta.

Fermented foods
Cultured or fermented foods provide probiotics, healthy bacteria that improve immune function and protect against cancer. These good bacteria can bind and destroy potential carcinogens, which may be especially effective in preventing colorectal cancer. Don’t like yogurt? Try something new, such as kefir, kombucha, kimchi or tempeh.  

Garlic 
Classified as a vegetable, cultures have long used garlic both for cooking and medicine. A root vegetable, garlic contains allicin, a protective sulfur compound that inhibits cancer progression. Eating garlic frequently lowers the risk of colorectal cancer but is also being studied for its role in reducing other cancers. When cooking with garlic, wait 15 minutes after you crush or chop garlic before heating to release the active ingredients. Use as a flavoring to any savory dish.

Cardio Renal Metabolic Syndrome Risk reduction

 it’s really common to have heart, kidney, and metabolic risk factors at the same time (AHA)

‘It is reassuring that once the CKM connection was explained, nearly three-quarters of those surveyed recognized its importance.’ 

Almost 90 percent of adults are plagued by a deadly heart condition without realizing it, 

new research has revealed

CKM syndrome highlights the way in which dysfunction in one system – the heart, kidneys, or metabolic system – can negatively affect the others. 

Together, these conditions greatly increase the risk of serious health outcomes such as heart attack, stroke, and heart failure.

According to the AHA, nearly 90 percent of US adults have at least one risk factor for 

CKM syndrome, including 

high blood pressure, 

abnormal cholesterol, 

high blood glucose (sugar), 

excess weight and 

reduced kidney function.

Unlike some chronic conditions, CKM syndrome is often reversible, especially when caught early. 

To categorize people’s risk of CKM, the AHA has come up with four stages. 

Stage zero is the optimum place to be. It represents people with no risk factors, who likely eat a balanced diet, are a healthy weight, and do not smoke.

Stage one is people who might be overweight, especially with excess belly fat. Or, they may have pre-diabetes.

It is advised that these people try to lose five percent of their weight to protect themselves from progressing into a further CKM stage.

People in stage two will be starting to experience things like high blood pressure and type 2 diabetes. 

They may also have kidney disease.

Doctors may prescribe this cohort medication to control their blood pressure, blood sugar and cholesterol.

They may also offer patients Ozempic or Wegovy, to help them lose weight and control blood sugar levels.

Stage three is when people have asymptomatic heart disease. 

They may have high blood pressure or early heart or kidney disease and may be on medication such as a statin.

Treatments for this category include heart and diabetes drugs, plus testing for narrowed arteries.

Stage four is symptomatic heart disease. 

This would be someone with diagnosed heart disease, excess fat, Type 2 diabetes or kidney disease. 

They may have already suffered heart attacks or strokes and developed heart failure.

1.Eat better

by choosing healthy whole foods.

2.Manage weight with healthy eating and regular activity.

3.Control cholesterol by choosing healthy fats.

4.Manage blood pressure

by lowering salt intake, getting good sleep, maintaining a healthy weight and staying active.

5.Be more active with regular physical activity you enjoy.

6.Get healthy sleep by aiming for 7-9 hours of sleep each night.

7.Manage blood sugar

by eating healthy, exercising and keeping a healthy weight.

8.Quit tobacco

by stopping use of inhaled nicotine delivery products which include traditional cigarettes, e-cigarettes, and vaping.

People in stage four can be further divided into those with kidney failure and those without it.

The AHA stresses the importance of lifestyle changes, including 

healthy eating, 

regular physical activity, and medical treatment when needed. 

The new survey revealed widespread misconceptions about how these systems interact. 

More than two-thirds (68 percent) of US adults incorrectly believe that it’s best to manage conditions like heart disease, kidney disease, or diabetes one at a time – or they weren’t sure. 

Additionally, 42 percent either believed a healthy heart could not be damaged by dysfunction in other organs or were unsure.

‘The heart, kidney, and metabolic systems are connected and, as such, should be treated in a coordinated way,’ said Dr Sanchez. 

‘These results highlight the need to better communicate that connection and the importance of collaborative care.’ 

To improve understanding and care, the AHA will publish the first-ever clinical guidelines on CKM syndrome in early 2026. 

These guidelines aim to help healthcare providers treat patients with multiple related conditions through a more integrated and patient-centered approach.

In the meantime, the AHA has launched the CKM Health Initiative, offering educational resources and tools for both the public and healthcare professionals. 

These include a new explainer video that breaks down how the body’s systems interact.

‘CKM health is about your overall health,’ said Dr. Sanchez. 

‘You can take care of your body 

with regular checks of your 

blood pressure, 

cholesterol, 

weight, 

blood sugar, and 

kidney function.’ 

The survey was conducted online by The Harris Poll on behalf of the AHA. Approximately 4,000 US adults participated

Metabolic Eating

A metabolic diet 

is a broad term for eating patterns that focus on boosting metabolism through nutrient-dense, whole foods. 

Key components often include 

lean proteins, 

whole grains, 

plenty of fruits and 

vegetables, and 

healthy fats. 

Many versions of 

“metabolic” diets emphasize 

eating balanced meals regularly 

may restrict 

🚫🍔processed foods, 

🚫🍬refined sugars, and 

🚫🧇sometimes certain CARBS

Key principles 

Prioritize whole foods: 

Focus on unprocessed foods like 

lean meats, 

fish, 

eggs, and 

legumes.

Include plenty of plants: 

Eat a variety of fruits, 

vegetables (especially leafy greens and 

non-starchy vegetables), 

whole grains 

-oats and 

-brown rice

Choose healthy fats: 

Incorporate healthy fats from sources like 

nuts, 

seeds, and 

olive oil. 

Eat balanced meals: 

Combine 

lean protein, 

complex carbohydrates, and 

healthy fats 

   to create a balanced plate. 

Avoid or limit refined foods: 

Cut back on 

🚫🍔processed items, 

🚫🍭refined sugars, and 

🚫🔲white flours. 

Stay hydrated:

🚰 Drink plenty of water to support metabolic processes. 

Eat regularly: 

♻️➰To maintain a steady energy source, some metabolic diets suggest eating smallermeals throughout the day. 

Foods to emphasize 

✅Lean proteins: 

🍗Chicken, 

🐟fish, 

🍳eggs, 

🫘beans, 

🟠lentils. 

✅Whole grains: 

🍘Brown rice, 

🔶oats, 

🌾barley. 

✅Non-starchy vegetables: 

🥦Broccoli, 

🥬spinach, 

🫑peppers. 

✅Fruits: 

🍓🫐Berries, 

🍏🍎apples, 

🍊oranges. 

✅Healthy fats: 

🥑Avocados, 

🌰nuts, 

▪️seeds,

🫒🛢️olive oil. 

✅Metabolism-boosting foods: 

Some studies suggest that foods like 🌶️chili peppers, 

☕️coffee, and 

🍵green tea 

   may slightly increase metabolic rate. 

Important considerations 

No one-size-fits-all approach: The best diet is versatile and tailored to your individual needs, preferences, and health goals. 

Consult a professional: 

Before making major changes, it is best to consult a healthcare provider or registered dietitian to create a personalized plan

Focus on more than just diet: Factors like 

regular physical activity, 

adequate sleep, and 

hydration are also crucial for 

a healthy metabolism. 

Gastroparesis

is primarily caused by vagus nerve damage, which most commonly stems from poorly controlled diabetes. Other causes include autoimmune diseases (like scleroderma), certain viral infections, some types of stomach surgery, and certain medications (such as opioids and some weight-loss drugs). In some cases, the cause remains unknown, a condition known as idiopathic gastroparesis. 

Common Causes & Risk Factors

  • Diabetes: High blood sugar levels can damage the vagus nerve, which controls stomach muscles. 
  • Surgery: Procedures on the stomach or esophagus can sometimes damage the vagus nerve. 
  • Infections: Some viral infections, including those from viruses like Epstein-Barr, Cytomegalovirus, and even COVID-19, can trigger the condition. 
  • Medications: Certain drugs, such as opioid pain medicines, anticholinergic drugs, and newer weight loss medications, can slow stomach emptying. 
  • Autoimmune Conditions: Diseases like scleroderma and lupus can attack the nerves and muscles of the stomach. 
  • Hypothyroidism: An underactive thyroid gland can lead to a generalized slowing of bodily processes, including stomach motility, causing delayed emptying. 

Idiopathic Gastroparesis 

  • In many instances, the precise cause of gastroparesis is not identified. This is known as idiopathic gastroparesis. 

Mechanism of Gastroparesis

  • Gastroparesis occurs when the vagus nerve is damaged or does not function correctly, preventing it from sending the proper signals to the stomach muscles. 
  • This damage results in stomach muscles contracting poorly, which leads to delayed emptying of food from the stomach into the small intestine. 

Obesity: A chronic disease

Obesity is a chronic disease, not just a matter of effort. It’s important to understand the influences of genetics, physiology, environment, job, education and what’s going on in the brain. 

What is obesity?

More than just weight gain

Obesity is a chronic disease caused by genetic, metabolic, behavioural, psychological and environmental factors. These factors together with the pleasure we derive from food can all influence energy balance, which in turn can lead to weight gainOnce established, powerful neuro-hormonal factors effectively defend the body against weight loss, thereby often making obesity a lifelong problem, where weight regain (or relapse) is the rule, rather than the exception.

Underdiagnosed and undertreated

Obesity affects 650 million adults worldwide – that’s approximately 13% of the world’s population. It is recognised by healthcare professionals, organisations and people across the world as a chronic disease which requires long-term management. The Awareness, Care and Treatment in Obesity Management – an International Observation (ACTION IO) Study* found that 68% of people with obesity and 88% of healthcare professionals believe that obesity is a chronic disease. Although both people with obesity and healthcare professionals recognise obesity as a chronic disease, it remains underdiagnosed and undertreated.

*The Awareness, Care and Treatment In Obesity Management – an International Observation (ACTION IO) Study is the first international study to investigate barriers to obesity management among people with obesity and healthcare professionals in 11 countries worldwide (Australia, Chile, Israel, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, UAE, UK). A total of 14,502 people with obesity and 2,785 healthcare professionals completed the survey.

What factors influence obesity as a disease?

Perhaps one of the reasons obesity continues to be poorly understood, underdiagnosed and undertreated, is that its causes are multifactorial. These causes can be physiological, psychological, genetic, environmental or socioeconomic. Many of these factors are outside of an individual’s control.

Environmental

Many aspects of our environment can contribute to the development of obesity, including exposure to oversized food portions, lack of physical activity due to high amounts of screen usage and easy access to unhealthy food.

Genetic

Some people are genetically predisposed to developing obesity, depending on their family history.

Physiological

Energy balance is a complex mechanism centrally regulated by the brain, with input from peripheral hormonal signals released from the gastrointestinal tract, pancreas and adipose tissue, which are integrated to regulate appetite and energy expenditure.

Psychological

Stress,15 boredom15 and psychological disorders are linked to overeating and can constribute to the development of obesity. 

Socio-economic

Where a person lives, the society in which they live and their income can also influence their chances of developing obesity. 

All about the science to obesity

Understanding the complexities of obesity goes beyond simplistic views of food availability and willpower, involving an intricate network of energy balance, metabolic adaptations, neurobiology, and hormonal influences.

Why is maintaining weight loss challenging?

A review of 14 long-term studies showed that one to two thirds of people with obesity regained more weight after weight loss achieved by dieting. Furthermore, the ACTION IO study found that  81% of people with obesity have engaged in one or more serious weight loss attempts; however, only 11% were able to maintain a 5% weight loss for one year or more.

Visual adapted from Mann T, Tomiyama AJ, Westling E, Lew AM, Samuels B, Chatman J. Medicare’s search for effective obesity treatments: diets are not the answer.  Am Psychol. 2007;622(3):220–233. 

Maintaining weight loss is challenging for people living with obesity, and findings such as from the ACTION IO study* show that obesity isn’t about willpower.

To understand what the effective strategies for obesity management are, we need to consider, physiological, psychological and biological factors of obesity. Although diet modification and exercise continue to be key in the management of obesity, increasingly patients require pharmacological adjuncts in order achieve or maintain weight loss.

It is also crucial to understand the multiple systems involved in the pathophysiology of obesity and interventions to tackle these could be essential in providing lasting weight loss.

*The Awareness, Care and Treatment in Obesity Management – an International Observation (ACTION IO) Study is the first international study to investigate barriers to obesity management among people with obesity and healthcare professionals in 11 countries worldwide (Australia, Chile, Israel, Italy, Japan, Mexico, Saudi Arabia, South Korea, Spain, UAE, UK). A total of 14,502 people with obesity and 2,785 healthcare professionals completed the survey.

Human Leukocyte Antigen – B27 and Axial spondyloarthritis (AxSpA)

is a gene which has a much higher positive prevalence in certain auto-immune/autoinflammatory diseases such as Spondyloarthritis, Uveitis/Iritis, Crohns Disease, Ulcerative Colitis and Psoriasis. Positive HLA-B27 affects people in multiple ways, when it comes to Spondyloarthritis in related to musculoskeletal (MSK). Approximately 90% (male) and 85% (female) positivity in AxSpA Approximately 40-50% positivity in Psoriatic Arthritis (PsA).

The prevalence of HLA-B27 positivity in the general population is around 8-12% although its frequency is lower in African American, South American and Middle Eastern populations than in others.HLA-B27 is the most important genetic factor for development risk of Axial spondyloarthritis (AxSpA) but there are other implicated genetic markers, all of which do vary for different populations.

Under-representation of the groups with lower HLA-B27 positivity in research and epidemiology is an issue and inclusion of these groups could provide information on other subsets. Don’t over rely on HLA-B27 in clinical practice, the interplay of the complicating factors of axial vs peripheral, population variations and HLA-B27 negative Spondyloarthritis means that interpretation is best left to Rheumatologists.

Epicardial Fat: 

A Key Driver in Obesity-Related HFpEF

The link between obesity & HFpEF is critical. 

Epicardial adipose tissue (EAT) 

is not just storage— it’s an active organ promoting myocardial dysfunction.

EAT drives: 

➡️Fibrosis 

➡️Inflammation 

➡️Oxidative stress 

➡️Diastolic dysfunction

Understanding EAT’s  is crucial for developing new personalized therapies. 

Heart failure with preserved ejection fraction (HFpEF) 

is a growing global health problem characterized by high morbidity and mortality, with limited effective therapies available. 

Obesity significantly influences haemodynamic and structural changes in the myocardium and vasculature, primarily through the accumulation and action of visceral adipose tissue. 

Particularly, epicardial adipose tissue (EAT) contributes to HFpEF through inflammationand lipotoxic infiltration of the myocardium. 

However, the precise signalling pathways leading to diastolic stiffness in HFpEF require further elucidation. 

This review explores the dynamic role of EAT in health and disease. 

Drawing upon insights from studies in other conditions, we discuss potential 

EAT-mediated inflammatory pathways in HFpEF and 

how they may contribute to functional and structural myocardial and endothelial derangements, including 

•intramyocardial lipid infiltration, •fibrosis, 

•endothelial dysfunction, •cardiomyocyte stiffening, and 

•left ventricular hypertrophy. 

Lastly, we propose potential targets for novel therapeutic avenues.

EAT as a therapeutic target in HFpEF

The phenotypic diversity of HFpEF and the interplay with different comorbiditieswarrant a tailored treatment approach. 

In the context of the obesity-related HFpEF phenotype, targeting the pathological transformation and underlying inflammatory pathways mediated by EAT may present new therapeutic avenues. 

We therefore present therapeutic options that pose a clinical benefit that arise from changes to EAT or EAT-mediated pathways.

1) Sodium-glucose cotransporter-2 inhibitors(SGLT2i), like dapagliflozin and empagliflozin, are the first type of pharmacological drugs to reduce the risk of heart failure–related hospitalization in HFpEF trials.

Given the low expression of SGLT2 in cardiomyocytes, it is likely that SGLT2i mediate their positive effects in HFpEF by off-target mechanisms in the myocardium.

At least in part, these effects might be mediated by EAT. 

Upon SGLT2i administration, EAT volume decreases and glucose uptake by EAT is enhanced, suggesting that these types of drugs might improve EAT’s secretome and may improve metabolic regulation associated with insulin resistance in obesity.

Furthermore, SGLT2i-treated patients show a reduction of ECM and cardiomyocyte volume, along with a decrease in inflammatory biomarkers, such as FABP4, IL-1, IL-6, and TGF-β, indicating a role in improving myocardial inflammation and fibrosis.

Additionally, SGLT2i show a mild, sustained diuretic effect that can improve volume overload and congestion seen in HFpEF, while reducing the need for diuretics use.

2)Glucagon-like peptide 1 agonists (GLP-1a), such as semaglutide and liraglutide, are a class of anti-diabetic drugs known for their glucose-lowering effects and insulin sensitization, which show a rapid and significant reduction of EAT thickness independent of body weight loss.

Clinical trials in patients with HFpEF show symptom reduction and exercise capacity improvement after GLP-1a administration, across the entire obesity spectrum.

It is suggested that part of the effect of GLP-1a might be mediated by EAT, given that this fat depot expresses specific GLP-1 receptors.

While GLP-1a primarily enhances insulin sensitivity, in EAT, it induces adipocyte browning through activation of the AMPK pathway and reduces local adipogenesis by improving FFA oxidation.

However, a reduction in EAT is likely accompanied by simultaneous reductions in other fat depots. GLP-1a reduces both VAT and SAT in equal proportions, and these reductions correspond with overall weight loss.

However, due to the presence of specific GLP-1 receptors on EAT, these agonists may directly remodel EAT into a more cardioprotective fat depot, and therefore have a direct effect mediated by EAT, independent of overall weight loss.

3)Bariatric surgery causes drastic and often lasting weight loss, triggering favourable metabolic changes in obese patients.

Significant weight loss is typically accompanied by a reduction of abdominal and visceral fat depots, including EAT.

Although robust and longitudinal data in patients with HFpEF is lacking, significant weight loss may improve haemodynamics, exercise capacity, and symptoms.

This effect could be mediated, at least in part, by reducing EAT-mediated pericardial constraint, which may alleviate pressure on the LV and improve its (diastolic) function.

4)Statins, particularly atorvastatin, show improved cholesterol profiles and reduction in EAT.

Known for their lipid-lowering and anti-inflammatory effects, statins could influence EAT expansion and hamper the secretion of proinflammatory molecules, contributing to improvements in cardiovascular health. 

While statins are not recommended in the guidelines for HFpEF treatment, they are often prescribed for patients with HFpEF to address cardiovascular comorbidities, such as hypertension, CAD, and dyslipidaemia.

Furthermore, some suggest that early initiation of statin use is associated with improved outcomes in HFpEF, although this is a topic of current debate.

Heart failure with preserved ejection fraction (HFpEF) 

is a growing global health problem characterized by high morbidity and mortality, with limited effective therapies available. 

Obesity significantly influences haemodynamic and structural changes in the myocardium and vasculature, primarily through the accumulation and action of visceral adipose tissue. 

Particularly, epicardial adipose tissue (EAT) contributes to HFpEF through inflammation and lipotoxic infiltration of the myocardium. 

However, the precise signalling pathways leading to diastolic stiffness in HFpEF require further elucidation. 

This review explores the dynamic role of EAT in health and disease. 

Drawing upon insights from studies in other conditions, we discuss potential 

EAT-mediated inflammatory pathways in HFpEF and 

how they may contribute to functional and structural myocardial and endothelial derangements, including 

intramyocardial lipid infiltration, fibrosis, 

endothelial dysfunction, cardiomyocyte stiffening, and left ventricular hypertrophy. 

Novel therapeutic avenues are available.

Melioidosis

is an infectious disease caused by a gram-negative bacterium called Burkholderia pseudomallei. Most people exposed to B. pseudomallei experience no symptoms, but complications can range from fever and skin changes to pneumonia, abscesses, and septic shock, which can be fatal. 

Approximately 10% of people with melioidosis develop symptoms that last longer than two months, termed “chronic melioidosis”. 

Melioidosis is a serious and often underdiagnosed infectious disease caused by the environmental bacterium Burkholderia pseudomallei. 

It’s sometimes called “Whitmore’s disease” and is endemic to tropical and subtropical regions, especially Southeast Asia, northern Australia, and increasingly parts of India. 

Melioidosis—caused by Burkholderia pseudomallei—has seen a surge of research interest recently, especially due to its expanding global footprint and potential as a biothreat. 

Recent advances: 

Emerging infections with Melioidosis—caused by Burkholderia pseudomallei—has seen a surge of research interest recently, especially due to its expanding global footprint and potential as a biothreat. —a highly pathogenic, Gram-negative β-proteobacterium. 

B. pseudomallei is a saprophyte found in soil, groundwater, stagnant streams, rice paddies, and ponds. 

Although melioidosis is mainly endemic in Southeast Asia and northern Australia, it is also increasingly reported in regions outside the Asia-Pacific region including India, Mauritius, the Americas, and Africa. 

Melioidosis can present as an acute, subacute, or chronic process. 

Disease manifestations

include subclinical infections, localized abscesses, severe pneumonia, and fulminant sepsis. 

Case fatality rates ranged from 19 to 36% in endemic areas. Although the epidemiology and routes of transmission are not yet fully understood, it is believed that melioidosis is acquired through contact with contaminated soil and water by percutaneous inoculation, inhalation of aerosols, and ingestion.

The incubation period of melioidosis varies widely from two days to 62 years. Human cases are often spatially and temporally clustered, following heavy rains and winds with resultant human exposure to soil and water B. pseudomallei also causes melioidosis in a wide range of animals in endemic areas. In Hong Kong, melioidosis is an endemic disease not only in humans but also in captive marine mammals and birds, including bottlenose dolphins, 

California sea lions, pilot whales, and zebra 

Transmission & Risk Factors. 

B. pseudomallei thrives in soil and surface water. Infection typically occurs through:• Inhalation of contaminated dust or water droplets• Ingestion of contaminated water or food• Direct contact with contaminated soil or water via skin abrasions or woundsHigh-risk groups include:• People with diabetes, chronic kidney or lung disease, cancer, or alcohol use disorder• Farmers, construction workers, and others exposed to muddy soil or floodwaters 

Clinical Manifestations

Melioidosis is known for its wide spectrum of presentations:• Localized infection: Skin ulcers, abscesses• Pulmonary infection: Cough, chest pain, high fever—often mistaken for TB-Tuberculosis & Chest Diseases

Localized Skin Infections. Swelling, redness, and ulceration around a woundAbscess formationPulmonary (Lung) InfectionCough, often with mucus or phlegm. Chest pain. Fever. Difficulty breathing

Septicemia (Blood Infection)

High fever and chills. 

Abdominal discomfort. 

Confusion or dizziness.

Muscle or joint pain 

Disseminated Infection 

Abscesses in multiple organs (liver, spleen, lungs). 

Weight loss and fatigueMuscle aches and joint pain. 

Disseminated infection: Sepsis, organ abscesses (liver, spleen, prostate), joint and bone involvement, neurological symptoms. 

Symptoms may appear within 1–3 weeks, but latent infections can emerge months or even years later.

Predisposing factors:

Diabetes mellitus is one of the most important risk factors in developing melioidosis. 

The disease should be considered in anyone who has spent time in endemic areas who develops a fever, pneumonia, or abscesses in their liver, spleen, prostate, or parotid gland. Latent infections as pseudomallei can remain latent in the human body for up to 29 years until it is reactivated during human immunosuppression or stress response. However, the site of bacteria during latent infection and the mechanism by which they avoid immune recognition for years are both unclear.
Amongst mechanisms suggested are: residing in the nucleus of the cell to prevent being digested, entering a stage of slower growth, antibiotic resistance, and genetic adaption to the host environment. 

Granulomas (containing neutrophils, macrophages, lymphocytes, and multinucleated giant cells) formed at the infection site in melioidosis have been associated with latent infection in humans.

Diagnosis & Treatment

Diagnosis: Blood or abscess fluid cultures are the gold standard.

Misdiagnosis is common.

Culture Microscopy. By microscopy, 

B. pseudomallei is seen as gram-negative and rod-shaped, with bipolar staining similar in appearance to a safety pin. 

Bacteria can sometimes be seen directly in clinical samples from infected people; however, identification by light microscopy is neither specific nor sensitive. Immunofluorescence microscopy is highly specific for detecting bacteria directly from clinical specimens, but has less than 50% sensitivity. Imaging 

Various imaging modalities can also help with the diagnosis of melioidosis. 

In acute melioidosis with the spreading of the bacteria through the bloodstream, the chest X-ray shows multifocal nodular lesions. 

It may also show merging nodules or cavitations. 

For those with acute melioidosis without the spread to the bloodstream, chest X-ray most commonly shows upper lobe consolidation or cavitations. In chronic melioidosis, the slow progression of upper lobe consolidation of the lungs resembles tuberculosis. 

For abscesses located in other parts of the body apart from the lungs, especially in the liver and spleen, CT scan has higher sensitivity when compared with an ultrasound scan. In liver and splenic abscesses, an ultrasound scan shows “target-like” lesions while a CT scan shows “honeycomb sign” (abscess with loculations separated by thin septa) in liver abscesses. 

For melioidosis involving the brain, MRI has higher sensitivity than a CT scan in diagnosing the lesion. MRI shows ring-enhancing lesions for brain melioidosis

Prevention

Bacterial culture has 60% sensitivity in diagnosing melioidosis.

B. pseudomallei is never part of human flora. Therefore, any growth of the bacteria is diagnostic of melioidosis.
Other samples such as throat, rectal swabs, pus from abscesses, and sputum can also be used for culture. However, culture from CSF is difficult because in one case series, only 29% of the neuromelioidosis cases are culture-positive. When bacteria do not grow from people strongly suspected of having melioidosis, repeated cultures should be taken as subsequent cultures can become positive B. pseudomallei can be grown on any blood agar, MacConkey agar, and agar containing antibiotics such as Ashdown’s medium (containing gentamicin)nand Ashdown’s broth (containing colistin for better isolation of B. pseudomallei from other types of bacteria. Agar plates for melioidosis should be incubated at 37 °C (98.6 °F) in air and inspected daily for four days. On the agar plates, B. pseudomallei forms creamy, non-haemolytic, colonies after 2 days of incubation. After 4 days of incubation, colonies appear dry and wrinkled. Colonies ofB. pseudomallei that are grown on Franci’s medium (a modification of Ashdown medium with gentamicin concentration increased to 8 mg/L and neutral red indicator replaced with 0.2% bromocresol purple) are yellowed to symptom overlap with TB and other infections.

Treatment:

Intensive phase: IV antibiotics (e.g., ceftazidime or meropenem) for 2–8 weeks

Eradication phase: Oral antibiotics (e.g., trimethoprim-sulfamethoxazole) for 3–6 months to prevent relapseDelayed diagnosis and treatment can lead to mortality rates as high as 90% in severe cases. doves. 

Treatment of melioidosis can be difficult, as B. pseudomallei is often resistant to multiple antibiotics, and a prolonged course of antibiotics is required to prevent disease relapse. Due to the severity of melioidosis and aerosol transmissibility of the infectious agent, B. pseudomallei has been classified as a category B bioterrorism and Tier 1 select agent by the Center for Disease Control, USA.

Prevention – Efforts to prevent melioidosis include: wearing protective gear while handling contaminated water or soil, practicing hand hygiene, drinking boiled water, and avoiding direct contact with soil, water, or heavy rain.

There is little evidence to support the use of melioidosis prophylaxis in humans. 

The antibiotic co-trimoxazole is used as a preventative only for individuals at high risk of getting the disease after being exposed to the bacteria in laboratory settings.

Public Health Implications. Melioidosis is increasingly recognized as a neglected tropical disease. 

Its burden is underestimated, especially in resource-limited settings. 

Climate change, extreme weather events, and expanding endemic zones (including parts of India) are raising global concern.

Vaccine Development Breakthroughs.

Researchers are actively pursuing vaccines to combat melioidosis, 

with several promising candidates emerging: Over the years, numerous different strategies have been explored to develop melioidosis vaccines. Based on the choice of protective antigens, many of the resulting candidates would also be predicted to provide some level of protection against Burkholderia mallei, the etiologic agent of glanders. Using these approaches, several promising melioidosis and glanders candidates have been identified with pre-clinical animal studies providing valuable insights into the immunogenic and protective capacities of these potential vaccines. Collectively, this review summarizes recent advancements in melioidosis vaccine research and highlights critical findings that will help guide a path toward the development of a safe, effective and affordable vaccine to combat disease caused by B. pseudomallei.- Subunit vaccinesusing protective antigens from B. pseudomallei have shown strong immunogenicity in preclinical modelsYet there are no vaccines available for humans 

Hand and Skin Hygiene. 

Wash hands thoroughly with soap and clean water after handling soil or water in affected areas, particularly before eating or drinking.

Vitamin D Benefits

Getting enough vitamin D helps the growth and development of bones and teeth. It may also provide improved resistance to certain diseases.

Vitamin D is a fat-soluble vitamin in a family of compounds that includes vitamins D1, D2, and D3.

Your body produces vitamin D naturally when it’s directly exposed to sunlight. You can also get vitamin D from certain foods and supplements to ensure adequate levels of the vitamin in your blood.

Vitamin D has several important functions. Perhaps the most vital are regulating the absorption of calcium and phosphorus and healthy immune system function. 

Getting enough vitamin D is important for the typical growth and development of bones and teeth and for improving resistance to certain diseases.

Here is more information about the benefits of vitamin D, its downsides, how much you need, and foods with vitamin D.

1. Vitamin D may fight disease

In addition to its primary benefits, research suggests that vitamin D may also play a role in:

Reducing the risk of multiple sclerosis (MS): A 2017 review
 of population-based studies found that low levels of vitamin D are linked with an increased risk of MS.

Decreasing the chance of heart disease: Low vitamin D levels have been linked to increased risk of heart diseases such as hypertension, heart failure, and stroke. However, it’s unclear
 whether vitamin D deficiency contributes to heart disease or indicates poor health when you have a chronic condition.

Reducing the likelihood of severe illnesses: Although studies
 are mixed, vitamin D may make severe flu and COVID-19 infections less likely. A recent review found that low vitamin D levels contribute to acute respiratory distress syndrome. 

Supporting immune health: People who do not have adequate vitamin D levels might be at increased risk of infections and autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes, and inflammatory bowel disease.

Build an understanding of your nutritional intake

Labcorp OnDemand’s Micronutrient Test may help you uncover nutritional deficiencies and make informed decisions about what you eat.

Clinics 5 miles away (95% of the U.S.)

HSA/FSA Payments Accepted

Walk-ins Welcome

4.8 ★’s on App Store

2. May regulate mood and reduce depression

Research has shown that vitamin D might play an important role in regulating mood and decreasing the risk of depression. A review of 7,534 people found that those experiencing negative emotions who received vitamin D supplements noticed an improvement in symptoms. Vitamin D supplementation may help people with depression who also have a vitamin D deficiency.

Another study identified low vitamin D levels as a risk factor for more severe fibromyalgiasymptoms, anxiety, and depression.

3. May support weight loss

People with higher body weights have a greater chance of low vitamin D levels, and some studies suggest there may be a link between vitamin D and obesity, though more research is needed to verify this.

In an older study, people taking daily calcium and vitamin D supplements lost more weight than subjects taking a placebo supplement. The researchers suggest that the extra calcium and vitamin D may have had an appetite-suppressing effect.

Current research doesn’t support the idea that vitamin D causes weight loss, but there appears to be a relationship between vitamin D and weight. 

Vitamin D deficiency 

Several factors can affect your ability to get adequate vitamin D from sunlight alone.

You may be less likely to absorb enough vitamin D from the sun if you:

live in an area with high pollution

use sunscreen

spend most of your time indoors

live in a big city where buildings block sunlight

have darker skin (The higher the levels of melanin, the less vitamin D your skin can absorb.

These factors can increase your risk of vitamin D deficiency, so it’s important to get some of your vitamin D from sources other than sunlight.

What are the signs you need vitamin D?

The symptoms of a vitamin D deficiency in adults may include:

tiredness, aches, and pains

severe bone or muscle pain or weakness

stress fractures, especially in your legs, pelvis, and hips

A healthcare professional can diagnose a vitamin D deficiency by performing a simple blood test. 

If you have a deficiency, your doctor may order X-rays to check the strength of your bones.

Is it good to take vitamin D every day?

If you receive a diagnosis of vitamin D deficiency, a healthcare professional will likely recommend that you take vitamin D supplements. If you have a severe deficiency, they may instead recommend high dose vitamin D tablets or liquids. 

You should also make sure to get vitamin D through sunlight and the foods you eat.

Risks of getting too much vitamin D

If you take excessive amounts of vitamin D supplements, you may get too much of it. However, this is unlikely to happen through diet or sun exposure because your body regulates the amount of vitamin D produced through sun exposure.

Vitamin D toxicity can lead to an increase in your blood calcium levels. This can result in a variety of health issues, such as:

frequent urination

apathy

vomiting

abdominal pain

dehydration

confusion

increased thirst

What food is highest in vitamin D?

Some foods contain vitamin D naturally, and others are fortified with it. You can find vitamin D 

in the following foods:

salmon

sardines

herring

canned tuna

cod liver oil

beef liver

egg yolk

regular mushrooms and those treated with ultraviolet light

milk (fortified)

certain cereals and oatmeals (fortified)

yogurt (fortified)

orange juice (fortified)

It can be hard to get enough vitamin D each day through sun exposure and food alone, so taking vitamin D supplements could help.

How much do you need?

There has been some debate over the amount of vitamin D required for optimal functioning. Recent studies indicate that we need more vitamin D than previously thought.

Some of the main controversies surrounding vitamin D

 are:

standardization of methods for measuring vitamin D levels

the difference between free and total vitamin D testing

defining low vitamin D status (insufficiency versus deficiency)

screening versus treatment

vitamin D threshold for the general population relative to a particular condition (such as pregnancy or nursing) and health issues (such as kidney failure or osteoporosis)

Blood serum levels considered adequate range from 50–100 nanomoles per liter (nmol/L). Depending on your blood level, you may need more vitamin D.

The Recommended Dietary Allowances for vitamin D are as follows: 

infants (0–12 months): 10 micrograms (mcg) or 400 international units (IU)Trusted Source

children and teens: 15 mcg (600 IU)

adults ages 18–70: 15 mcg (600 IU)

adults over age 70: 20 mcg (800 IU)

pregnant people or those who are breastfeeding to chestfeeding: 15 mcg (600 IU)

Frequently asked questions

What does vitamin D help with the most?

Vitamin D mainly helps the body absorb and retain calcium and phosphorus, which are crucial for maintaining strong bones. This means it’s really important for bone health.

How can I raise my vitamin D level quickly?

To increase your vitamin D levels, you can spend more time in the sun, take a supplement, and include certain foods in your diet. If you spend more time outdoors, make sure to use sunscreen.

Just one thing

Try this today: Add fish to your diet a couple of times per week to help boost your vitamin D intake. Try salmon in a mustard sauce, grilled sardines, or canned tuna on a salad to create different meal options.

The bottom line

Vitamin D has many potential benefits. It may reduce the risk of certain diseases, help improve mood reduce depression symptoms, and help with weight management. 

It’s hard to get enough vitamin D through your diet alone, so you may want to ask a healthcare professional for a blood test and consider taking a vitamin D supplement. 

25-Hydroxy Vitamin D Test

Doctors use the 25-hydroxy vitamin D test to monitor your vitamin D levels. Low levels can mean you need to spend more time outdoors or adjust your diet. But it can also occur with certain medical conditions.

Vitamin D helps your body absorb calcium and maintain strong bones throughout your entire life. Your body produces vitamin D when the sun’s UV rays contact your skin. Other good sources of the vitamin include fish, eggs, and fortified dairy products. It’s also available as a dietary supplement.

Vitamin D must go through several processes in your body before your body can use it. The first transformation occurs in the liver. Here, your body converts vitamin D to a chemical known as 25-hydroxyvitamin D, also called calcidiol.

The 25-hydroxy vitamin D test is the best way to monitor vitamin D levels. The amount of 25-hydroxyvitamin D in your blood is a good indication of how much vitamin D your body has. The test can determine if your vitamin D levels are too high or too low.

The test is also known as the 25-OH vitamin D test and the calcidiol 25-hydroxycholecalcifoerol test. It can be an important indicator of osteoporosis (bone weakness) and rickets (bone malformation).

Why is a 25-hydroxy vitamin D test done?

Your doctor may request a 25-hydroxy vitamin D test for several different reasons. It can help them figure out whether too much or too little vitamin D is causing bone weakness or other abnormalities. It can also monitor people who are at risk for having a vitamin D deficiency.

Those who are at high risk of having low levels of vitamin D include:

people who don’t get much exposure to the sun

older adults

people with obesity

babies who are breastfed only (formula is usually fortified with vitamin D)

people who have had gastric bypass surgery

people who have a disease that affects the intestines and makes it difficult for the body to absorb nutrients, such as Crohn’s disease

Your doctor may also want you to do a 25-hydroxy vitamin D test if they’ve already diagnosed you with a vitamin D deficiency and want to see if treatment is working.

How is the 25-hydroxy vitamin D test performed?

Your doctor will tell you not to eat anything for four to eight hours before the test.

The 25-hydroxy vitamin D test requires a common blood test. Your healthcare provider will draw blood from a vein in your arm using a needle. A quick finger prick will more than likely provide enough for a blood sample in children and infants.

Evaluating the results of a 25-hydroxy vitamin D test

Results will depend on your age, sex, and the testing methods used. Results can also slightly vary from lab to lab.

According to the Office of Dietary Supplements (ODS), levels of vitamin D are measured by the 25-hydroxy level in nanomoles/liter (nmol/L) or nanograms/milliliter (ng/mL). The results can indicate the following:

deficiency: less than 30 nmol/L (12 ng/mL)

potential deficiency: between 30 nmol/L (12 ng/mL) and 50 nmol/L (20 ng/mL)

normal levels: between 50 nmol/L (20 ng/mL) and 125 nmol/L (50 ng/mL)

high levels: higher than 125 nmol/L (50 ng/mL)

If your vitamin D levels are low and you’re having symptoms of bone pain, a doctor may recommend a special scan to check bone density. 

Doctors use this painless scan to evaluate a person’s bone health.

Low blood levels of 25-hydroxy vitamin D usually mean one (or more) of the following:

you aren’t eating a balanced, complete diet

your intestines aren’t absorbing the vitamin properly

you’re not spending enough time outside to absorb adequate vitamin D levels through sun exposure

Some evidence links vitamin D deficiency to a higher risk of certain cancers, immune diseases, and cardiovascular disease.

High vitamin D blood levels generally result from taking too many vitamin pills and other nutritional supplements. High doses of vitamin D can result in a condition called hypervitaminosis D. Hypervitaminosis is a rare but serious condition that could put you at risk for liver or kidney problems.

High levels are rarely due to consuming too much of the vitamin through foods or sun exposure.

Your doctor will help explain the results of your test and determine if you have a vitamin D deficiency.

Risks of a 25-hydroxy vitamin D test

As with any routine blood test, risks of the 25-hydroxy vitamin test are minimal and include: 

excessive bleeding

lightheadedness

a slight chance of infection where the needle pierces your skin

Outlook

Vitamin D is vital to the body. Deficiencies at any age can cause problems.

Your doctor may recommend supplements or other treatment options if you’re very deficient. Eating foods that contain vitamin D in addition to adding supplements to your regimen can help keep your vitamin D levels stable.

css.php